Medical Billing Code Search
What is a code?
75106 results found
| T44.1X6S | Underdosing of other parasympathomimetics [cholinergics], sequela |
| T44.2X1A | Poisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter |
| T44.2X1D | Poisoning by ganglionic blocking drugs, accidental (unintentional), subsequent encounter |
| T44.2X1S | Poisoning by ganglionic blocking drugs, accidental (unintentional), sequela |
| T44.2X2A | Poisoning by ganglionic blocking drugs, intentional self-harm, initial encounter |
| T44.2X2D | Poisoning by ganglionic blocking drugs, intentional self-harm, subsequent encounter |
| T44.2X2S | Poisoning by ganglionic blocking drugs, intentional self-harm, sequela |
| T44.2X3A | Poisoning by ganglionic blocking drugs, assault, initial encounter |
| T44.2X3D | Poisoning by ganglionic blocking drugs, assault, subsequent encounter |
| T44.2X3S | Poisoning by ganglionic blocking drugs, assault, sequela |
| T44.2X4A | Poisoning by ganglionic blocking drugs, undetermined, initial encounter |
| T44.2X4D | Poisoning by ganglionic blocking drugs, undetermined, subsequent encounter |
| T44.2X4S | Poisoning by ganglionic blocking drugs, undetermined, sequela |
| T44.2X5A | Adverse effect of ganglionic blocking drugs, initial encounter |
| T44.2X5D | Adverse effect of ganglionic blocking drugs, subsequent encounter |
| T44.2X5S | Adverse effect of ganglionic blocking drugs, sequela |
| T44.2X6A | Underdosing of ganglionic blocking drugs, initial encounter |
| T44.2X6D | Underdosing of ganglionic blocking drugs, subsequent encounter |
| T44.2X6S | Underdosing of ganglionic blocking drugs, sequela |
| T44.3X1A | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter |
| T44.3X1D | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter |
| T44.3X1S | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), sequela |
| T44.3X2A | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter |
| T44.3X2D | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter |
| T44.3X2S | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, sequela |
| T44.3X3A | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter |
| T44.3X3D | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter |
| T44.3X3S | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela |
| T44.3X4A | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter |
| T44.3X4D | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter |
| T44.3X4S | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela |
| T44.3X5A | Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter |
| T44.3X5D | Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter |
| T44.3X5S | Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela |
| T44.3X6A | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter |
| T44.3X6D | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter |
| T44.3X6S | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela |
| T44.4X1A | Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter |
| T44.4X1D | Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter |
| T44.4X1S | Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela |
| T44.4X2A | Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter |
| T44.4X2D | Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter |
| T44.4X2S | Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela |
| T44.4X3A | Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter |
| T44.4X3D | Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter |
| T44.4X3S | Poisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela |
| T44.4X4A | Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter |
| T44.4X4D | Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter |
| T44.4X4S | Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela |
| T44.4X5A | Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter |
| T44.4X5D | Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter |
| T44.4X5S | Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela |
| T44.4X6A | Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter |
| T44.4X6D | Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter |
| T44.4X6S | Underdosing of predominantly alpha-adrenoreceptor agonists, sequela |
| T44.5X1A | Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter |
| T44.5X1D | Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter |
| T44.5X1S | Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela |
| T44.5X2A | Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter |
| T44.5X2D | Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter |
| T44.5X2S | Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequela |
| T44.5X3A | Poisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter |
| T44.5X3D | Poisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter |
| T44.5X3S | Poisoning by predominantly beta-adrenoreceptor agonists, assault, sequela |
| T44.5X4A | Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter |
| T44.5X4D | Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter |
| T44.5X4S | Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, sequela |
| T44.5X5A | Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter |
| T44.5X5D | Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter |
| T44.5X5S | Adverse effect of predominantly beta-adrenoreceptor agonists, sequela |
| T44.5X6A | Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter |
| T44.5X6D | Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter |
| T44.5X6S | Underdosing of predominantly beta-adrenoreceptor agonists, sequela |
| T44.6X1A | Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), initial encounter |
| T44.6X1D | Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter |
| T44.6X1S | Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), sequela |
| T44.6X2A | Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, initial encounter |
| T44.6X2D | Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, subsequent encounter |
| T44.6X2S | Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, sequela |
| T44.6X3A | Poisoning by alpha-adrenoreceptor antagonists, assault, initial encounter |
| T44.6X3D | Poisoning by alpha-adrenoreceptor antagonists, assault, subsequent encounter |
| T44.6X3S | Poisoning by alpha-adrenoreceptor antagonists, assault, sequela |
| T44.6X4A | Poisoning by alpha-adrenoreceptor antagonists, undetermined, initial encounter |
| T44.6X4D | Poisoning by alpha-adrenoreceptor antagonists, undetermined, subsequent encounter |
| T44.6X4S | Poisoning by alpha-adrenoreceptor antagonists, undetermined, sequela |
| T44.6X5A | Adverse effect of alpha-adrenoreceptor antagonists, initial encounter |
| T44.6X5D | Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter |
| T44.6X5S | Adverse effect of alpha-adrenoreceptor antagonists, sequela |
| T44.6X6A | Underdosing of alpha-adrenoreceptor antagonists, initial encounter |
| T44.6X6D | Underdosing of alpha-adrenoreceptor antagonists, subsequent encounter |
| T44.6X6S | Underdosing of alpha-adrenoreceptor antagonists, sequela |
| T44.7X1A | Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), initial encounter |
| T44.7X1D | Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter |
| T44.7X1S | Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), sequela |
| T44.7X2A | Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter |
| T44.7X2D | Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, subsequent encounter |
| T44.7X2S | Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, sequela |
| T44.7X3A | Poisoning by beta-adrenoreceptor antagonists, assault, initial encounter |
| T44.7X3D | Poisoning by beta-adrenoreceptor antagonists, assault, subsequent encounter |
| T44.7X3S | Poisoning by beta-adrenoreceptor antagonists, assault, sequela |
| T44.7X4A | Poisoning by beta-adrenoreceptor antagonists, undetermined, initial encounter |
| T44.7X4D | Poisoning by beta-adrenoreceptor antagonists, undetermined, subsequent encounter |
| T44.7X4S | Poisoning by beta-adrenoreceptor antagonists, undetermined, sequela |
| T44.7X5A | Adverse effect of beta-adrenoreceptor antagonists, initial encounter |
| T44.7X5D | Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter |
| T44.7X5S | Adverse effect of beta-adrenoreceptor antagonists, sequela |
| T44.7X6A | Underdosing of beta-adrenoreceptor antagonists, initial encounter |
| T44.7X6D | Underdosing of beta-adrenoreceptor antagonists, subsequent encounter |
| T44.7X6S | Underdosing of beta-adrenoreceptor antagonists, sequela |
| T44.8X1A | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), initial encounter |
| T44.8X1D | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), subsequent encounter |
| T44.8X1S | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), sequela |
| T44.8X2A | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, initial encounter |
| T44.8X2D | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, subsequent encounter |
| T44.8X2S | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, sequela |
| T44.8X3A | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, initial encounter |
| T44.8X3D | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, subsequent encounter |
| T44.8X3S | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, sequela |
| T44.8X4A | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, initial encounter |
| T44.8X4D | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, subsequent encounter |
| T44.8X4S | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, sequela |
| T44.8X5A | Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter |
| T44.8X5D | Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter |
| T44.8X5S | Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela |
| T44.8X6A | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, initial encounter |
| T44.8X6D | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter |
| T44.8X6S | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, sequela |
| T44.901A | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter |
| T44.901D | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter |
| T44.901S | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), sequela |
| T44.902A | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, initial encounter |
| T44.902D | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter |
| T44.902S | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, sequela |
| T44.903A | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, initial encounter |
| T44.903D | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, subsequent encounter |
| T44.903S | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, sequela |
| T44.904A | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, initial encounter |
| T44.904D | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, subsequent encounter |
| T44.904S | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, sequela |
| T44.905A | Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter |
| T44.905D | Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter |
| T44.905S | Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela |
| T44.906A | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounter |
| T44.906D | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter |
| T44.906S | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, sequela |
| T44.991A | Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter |
| T44.991D | Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter |
| T44.991S | Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), sequela |
| T44.992A | Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, initial encounter |
| T44.992D | Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter |
| T44.992S | Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, sequela |
| T44.993A | Poisoning by other drug primarily affecting the autonomic nervous system, assault, initial encounter |
| T44.993D | Poisoning by other drug primarily affecting the autonomic nervous system, assault, subsequent encounter |
| T44.993S | Poisoning by other drug primarily affecting the autonomic nervous system, assault, sequela |
| T44.994A | Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, initial encounter |
| T44.994D | Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, subsequent encounter |
| T44.994S | Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, sequela |
| T44.995A | Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter |
| T44.995D | Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter |
| T44.995S | Adverse effect of other drug primarily affecting the autonomic nervous system, sequela |
| T44.996A | Underdosing of other drug primarily affecting the autonomic nervous system, initial encounter |
| T44.996D | Underdosing of other drug primarily affecting the autonomic nervous system, subsequent encounter |
| T44.996S | Underdosing of other drug primarily affecting the autonomic nervous system, sequela |
| T45.0X1A | Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter |
| T45.0X1D | Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), subsequent encounter |
| T45.0X1S | Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), sequela |
| T45.0X2A | Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter |
| T45.0X2D | Poisoning by antiallergic and antiemetic drugs, intentional self-harm, subsequent encounter |
| T45.0X2S | Poisoning by antiallergic and antiemetic drugs, intentional self-harm, sequela |
| T45.0X3A | Poisoning by antiallergic and antiemetic drugs, assault, initial encounter |
| T45.0X3D | Poisoning by antiallergic and antiemetic drugs, assault, subsequent encounter |
| T45.0X3S | Poisoning by antiallergic and antiemetic drugs, assault, sequela |
| T45.0X4A | Poisoning by antiallergic and antiemetic drugs, undetermined, initial encounter |
| T45.0X4D | Poisoning by antiallergic and antiemetic drugs, undetermined, subsequent encounter |
| T45.0X4S | Poisoning by antiallergic and antiemetic drugs, undetermined, sequela |
| T45.0X5A | Adverse effect of antiallergic and antiemetic drugs, initial encounter |
| T45.0X5D | Adverse effect of antiallergic and antiemetic drugs, subsequent encounter |
| T45.0X5S | Adverse effect of antiallergic and antiemetic drugs, sequela |
| T45.0X6A | Underdosing of antiallergic and antiemetic drugs, initial encounter |
| T45.0X6D | Underdosing of antiallergic and antiemetic drugs, subsequent encounter |
| T45.0X6S | Underdosing of antiallergic and antiemetic drugs, sequela |
| T45.1X1A | Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter |
| T45.1X1D | Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), subsequent encounter |
| T45.1X1S | Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), sequela |
| T45.1X2A | Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter |
| T45.1X2D | Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, subsequent encounter |
| T45.1X2S | Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela |
| T45.1X3A | Poisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter |
| T45.1X3D | Poisoning by antineoplastic and immunosuppressive drugs, assault, subsequent encounter |
| T45.1X3S | Poisoning by antineoplastic and immunosuppressive drugs, assault, sequela |
| T45.1X4A | Poisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter |
| T45.1X4D | Poisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter |
| T45.1X4S | Poisoning by antineoplastic and immunosuppressive drugs, undetermined, sequela |
| T45.1X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter |
| T45.1X5D | Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter |
| T45.1X5S | Adverse effect of antineoplastic and immunosuppressive drugs, sequela |
| T45.1X6A | Underdosing of antineoplastic and immunosuppressive drugs, initial encounter |
| T45.1X6D | Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter |
| T45.1X6S | Underdosing of antineoplastic and immunosuppressive drugs, sequela |
| T45.2X1A | Poisoning by vitamins, accidental (unintentional), initial encounter |
| T45.2X1D | Poisoning by vitamins, accidental (unintentional), subsequent encounter |
| T45.2X1S | Poisoning by vitamins, accidental (unintentional), sequela |
| T45.2X2A | Poisoning by vitamins, intentional self-harm, initial encounter |
| T45.2X2D | Poisoning by vitamins, intentional self-harm, subsequent encounter |
| T45.2X2S | Poisoning by vitamins, intentional self-harm, sequela |
| T45.2X3A | Poisoning by vitamins, assault, initial encounter |
| T45.2X3D | Poisoning by vitamins, assault, subsequent encounter |
| T45.2X3S | Poisoning by vitamins, assault, sequela |
| T45.2X4A | Poisoning by vitamins, undetermined, initial encounter |
| T45.2X4D | Poisoning by vitamins, undetermined, subsequent encounter |
| T45.2X4S | Poisoning by vitamins, undetermined, sequela |
| T45.2X5A | Adverse effect of vitamins, initial encounter |
| T45.2X5D | Adverse effect of vitamins, subsequent encounter |
| T45.2X5S | Adverse effect of vitamins, sequela |
| T45.2X6A | Underdosing of vitamins, initial encounter |
| T45.2X6D | Underdosing of vitamins, subsequent encounter |
| T45.2X6S | Underdosing of vitamins, sequela |
| T45.3X1A | Poisoning by enzymes, accidental (unintentional), initial encounter |
| T45.3X1D | Poisoning by enzymes, accidental (unintentional), subsequent encounter |
| T45.3X1S | Poisoning by enzymes, accidental (unintentional), sequela |
| T45.3X2A | Poisoning by enzymes, intentional self-harm, initial encounter |
| T45.3X2D | Poisoning by enzymes, intentional self-harm, subsequent encounter |
| T45.3X2S | Poisoning by enzymes, intentional self-harm, sequela |
| T45.3X3A | Poisoning by enzymes, assault, initial encounter |
| T45.3X3D | Poisoning by enzymes, assault, subsequent encounter |
| T45.3X3S | Poisoning by enzymes, assault, sequela |
| T45.3X4A | Poisoning by enzymes, undetermined, initial encounter |
| T45.3X4D | Poisoning by enzymes, undetermined, subsequent encounter |
| T45.3X4S | Poisoning by enzymes, undetermined, sequela |
| T45.3X5A | Adverse effect of enzymes, initial encounter |
| T45.3X5D | Adverse effect of enzymes, subsequent encounter |
| T45.3X5S | Adverse effect of enzymes, sequela |
| T45.3X6A | Underdosing of enzymes, initial encounter |
| T45.3X6D | Underdosing of enzymes, subsequent encounter |
| T45.3X6S | Underdosing of enzymes, sequela |
| T45.4X1A | Poisoning by iron and its compounds, accidental (unintentional), initial encounter |
| T45.4X1D | Poisoning by iron and its compounds, accidental (unintentional), subsequent encounter |
| T45.4X1S | Poisoning by iron and its compounds, accidental (unintentional), sequela |
| T45.4X2A | Poisoning by iron and its compounds, intentional self-harm, initial encounter |
| T45.4X2D | Poisoning by iron and its compounds, intentional self-harm, subsequent encounter |
| T45.4X2S | Poisoning by iron and its compounds, intentional self-harm, sequela |
| T45.4X3A | Poisoning by iron and its compounds, assault, initial encounter |
| T45.4X3D | Poisoning by iron and its compounds, assault, subsequent encounter |
| T45.4X3S | Poisoning by iron and its compounds, assault, sequela |
| T45.4X4A | Poisoning by iron and its compounds, undetermined, initial encounter |
| T45.4X4D | Poisoning by iron and its compounds, undetermined, subsequent encounter |
| T45.4X4S | Poisoning by iron and its compounds, undetermined, sequela |
| T45.4X5A | Adverse effect of iron and its compounds, initial encounter |
| T45.4X5D | Adverse effect of iron and its compounds, subsequent encounter |
| T45.4X5S | Adverse effect of iron and its compounds, sequela |
| T45.4X6A | Underdosing of iron and its compounds, initial encounter |
| T45.4X6D | Underdosing of iron and its compounds, subsequent encounter |
| T45.4X6S | Underdosing of iron and its compounds, sequela |
| T45.511A | Poisoning by anticoagulants, accidental (unintentional), initial encounter |
| T45.511D | Poisoning by anticoagulants, accidental (unintentional), subsequent encounter |
| T45.511S | Poisoning by anticoagulants, accidental (unintentional), sequela |
| T45.512A | Poisoning by anticoagulants, intentional self-harm, initial encounter |
| T45.512D | Poisoning by anticoagulants, intentional self-harm, subsequent encounter |
| T45.512S | Poisoning by anticoagulants, intentional self-harm, sequela |
| T45.513A | Poisoning by anticoagulants, assault, initial encounter |
| T45.513D | Poisoning by anticoagulants, assault, subsequent encounter |
| T45.513S | Poisoning by anticoagulants, assault, sequela |
| T45.514A | Poisoning by anticoagulants, undetermined, initial encounter |
| T45.514D | Poisoning by anticoagulants, undetermined, subsequent encounter |
| T45.514S | Poisoning by anticoagulants, undetermined, sequela |
| T45.515A | Adverse effect of anticoagulants, initial encounter |
| T45.515D | Adverse effect of anticoagulants, subsequent encounter |
| T45.515S | Adverse effect of anticoagulants, sequela |
| T45.516A | Underdosing of anticoagulants, initial encounter |
| T45.516D | Underdosing of anticoagulants, subsequent encounter |
| T45.516S | Underdosing of anticoagulants, sequela |
| T45.521A | Poisoning by antithrombotic drugs, accidental (unintentional), initial encounter |
| T45.521D | Poisoning by antithrombotic drugs, accidental (unintentional), subsequent encounter |
| T45.521S | Poisoning by antithrombotic drugs, accidental (unintentional), sequela |
| T45.522A | Poisoning by antithrombotic drugs, intentional self-harm, initial encounter |
| T45.522D | Poisoning by antithrombotic drugs, intentional self-harm, subsequent encounter |
| T45.522S | Poisoning by antithrombotic drugs, intentional self-harm, sequela |
| T45.523A | Poisoning by antithrombotic drugs, assault, initial encounter |
| T45.523D | Poisoning by antithrombotic drugs, assault, subsequent encounter |
| T45.523S | Poisoning by antithrombotic drugs, assault, sequela |
| T45.524A | Poisoning by antithrombotic drugs, undetermined, initial encounter |
| T45.524D | Poisoning by antithrombotic drugs, undetermined, subsequent encounter |
| T45.524S | Poisoning by antithrombotic drugs, undetermined, sequela |
| T45.525A | Adverse effect of antithrombotic drugs, initial encounter |
| T45.525D | Adverse effect of antithrombotic drugs, subsequent encounter |
| T45.525S | Adverse effect of antithrombotic drugs, sequela |
| T45.526A | Underdosing of antithrombotic drugs, initial encounter |
| T45.526D | Underdosing of antithrombotic drugs, subsequent encounter |
| T45.526S | Underdosing of antithrombotic drugs, sequela |
| T45.601A | Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), initial encounter |
| T45.601D | Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter |
| T45.601S | Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), sequela |
| T45.602A | Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, initial encounter |
| T45.602D | Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter |
| T45.602S | Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, sequela |
| T45.603A | Poisoning by unspecified fibrinolysis-affecting drugs, assault, initial encounter |
| T45.603D | Poisoning by unspecified fibrinolysis-affecting drugs, assault, subsequent encounter |
| T45.603S | Poisoning by unspecified fibrinolysis-affecting drugs, assault, sequela |
| T45.604A | Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, initial encounter |
| T45.604D | Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, subsequent encounter |
| T45.604S | Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, sequela |
| T45.605A | Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter |
| T45.605D | Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter |
| T45.605S | Adverse effect of unspecified fibrinolysis-affecting drugs, sequela |
| T45.606A | Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter |
| T45.606D | Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter |
| T45.606S | Underdosing of unspecified fibrinolysis-affecting drugs, sequela |
| T45.611A | Poisoning by thrombolytic drug, accidental (unintentional), initial encounter |
| T45.611D | Poisoning by thrombolytic drug, accidental (unintentional), subsequent encounter |
| T45.611S | Poisoning by thrombolytic drug, accidental (unintentional), sequela |
| T45.612A | Poisoning by thrombolytic drug, intentional self-harm, initial encounter |
| T45.612D | Poisoning by thrombolytic drug, intentional self-harm, subsequent encounter |
| T45.612S | Poisoning by thrombolytic drug, intentional self-harm, sequela |
| T45.613A | Poisoning by thrombolytic drug, assault, initial encounter |
| T45.613D | Poisoning by thrombolytic drug, assault, subsequent encounter |
| T45.613S | Poisoning by thrombolytic drug, assault, sequela |
| T45.614A | Poisoning by thrombolytic drug, undetermined, initial encounter |
| T45.614D | Poisoning by thrombolytic drug, undetermined, subsequent encounter |
| T45.614S | Poisoning by thrombolytic drug, undetermined, sequela |
| T45.615A | Adverse effect of thrombolytic drugs, initial encounter |
| T45.615D | Adverse effect of thrombolytic drugs, subsequent encounter |
| T45.615S | Adverse effect of thrombolytic drugs, sequela |
| T45.616A | Underdosing of thrombolytic drugs, initial encounter |
| T45.616D | Underdosing of thrombolytic drugs, subsequent encounter |
| T45.616S | Underdosing of thrombolytic drugs, sequela |
| T45.621A | Poisoning by hemostatic drug, accidental (unintentional), initial encounter |
| T45.621D | Poisoning by hemostatic drug, accidental (unintentional), subsequent encounter |
| T45.621S | Poisoning by hemostatic drug, accidental (unintentional), sequela |
| T45.622A | Poisoning by hemostatic drug, intentional self-harm, initial encounter |
| T45.622D | Poisoning by hemostatic drug, intentional self-harm, subsequent encounter |
| T45.622S | Poisoning by hemostatic drug, intentional self-harm, sequela |
| T45.623A | Poisoning by hemostatic drug, assault, initial encounter |
| T45.623D | Poisoning by hemostatic drug, assault, subsequent encounter |
| T45.623S | Poisoning by hemostatic drug, assault, sequela |
| T45.624A | Poisoning by hemostatic drug, undetermined, initial encounter |
| T45.624D | Poisoning by hemostatic drug, undetermined, subsequent encounter |
| T45.624S | Poisoning by hemostatic drug, undetermined, sequela |
| T45.625A | Adverse effect of hemostatic drug, initial encounter |
| T45.625D | Adverse effect of hemostatic drug, subsequent encounter |
| T45.625S | Adverse effect of hemostatic drug, sequela |
| T45.626A | Underdosing of hemostatic drugs, initial encounter |
| T45.626D | Underdosing of hemostatic drugs, subsequent encounter |
| T45.626S | Underdosing of hemostatic drugs, sequela |
| T45.691A | Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter |
| T45.691D | Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter |
| T45.691S | Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), sequela |
| T45.692A | Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter |
| T45.692D | Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter |
| T45.692S | Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela |
| T45.693A | Poisoning by other fibrinolysis-affecting drugs, assault, initial encounter |
| T45.693D | Poisoning by other fibrinolysis-affecting drugs, assault, subsequent encounter |
| T45.693S | Poisoning by other fibrinolysis-affecting drugs, assault, sequela |
| T45.694A | Poisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter |
| T45.694D | Poisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter |
| T45.694S | Poisoning by other fibrinolysis-affecting drugs, undetermined, sequela |
| T45.695A | Adverse effect of other fibrinolysis-affecting drugs, initial encounter |
| T45.695D | Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter |
| T45.695S | Adverse effect of other fibrinolysis-affecting drugs, sequela |
| T45.696A | Underdosing of other fibrinolysis-affecting drugs, initial encounter |
| T45.696D | Underdosing of other fibrinolysis-affecting drugs, subsequent encounter |
| T45.696S | Underdosing of other fibrinolysis-affecting drugs, sequela |
| T45.7X1A | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter |
| T45.7X1D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter |
| T45.7X1S | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela |
| T45.7X2A | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter |
| T45.7X2D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter |
| T45.7X2S | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela |
| T45.7X3A | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter |
| T45.7X3D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter |
| T45.7X3S | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela |
| T45.7X4A | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter |
| T45.7X4D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter |
| T45.7X4S | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela |
| T45.7X5A | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter |
| T45.7X5D | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter |
| T45.7X5S | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela |
| T45.7X6A | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter |
| T45.7X6D | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter |
| T45.7X6S | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela |
| T45.8X1A | Poisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter |
| T45.8X1D | Poisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter |
| T45.8X1S | Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela |
| T45.8X2A | Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter |
| T45.8X2D | Poisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter |
| T45.8X2S | Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela |
| T45.8X3A | Poisoning by other primarily systemic and hematological agents, assault, initial encounter |
| T45.8X3D | Poisoning by other primarily systemic and hematological agents, assault, subsequent encounter |
| T45.8X3S | Poisoning by other primarily systemic and hematological agents, assault, sequela |
| T45.8X4A | Poisoning by other primarily systemic and hematological agents, undetermined, initial encounter |
| T45.8X4D | Poisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter |
| T45.8X4S | Poisoning by other primarily systemic and hematological agents, undetermined, sequela |
| T45.8X5A | Adverse effect of other primarily systemic and hematological agents, initial encounter |
| T45.8X5D | Adverse effect of other primarily systemic and hematological agents, subsequent encounter |
| T45.8X5S | Adverse effect of other primarily systemic and hematological agents, sequela |
| T45.8X6A | Underdosing of other primarily systemic and hematological agents, initial encounter |
| T45.8X6D | Underdosing of other primarily systemic and hematological agents, subsequent encounter |
| T45.8X6S | Underdosing of other primarily systemic and hematological agents, sequela |
| T45.91XA | Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter |
| T45.91XD | Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter |
| T45.91XS | Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela |
| T45.92XA | Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter |
| T45.92XD | Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter |
| T45.92XS | Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela |
| T45.93XA | Poisoning by unspecified primarily systemic and hematological agent, assault, initial encounter |
| T45.93XD | Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter |
| T45.93XS | Poisoning by unspecified primarily systemic and hematological agent, assault, sequela |
| T45.94XA | Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter |
| T45.94XD | Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter |
| T45.94XS | Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela |
| T45.95XA | Adverse effect of unspecified primarily systemic and hematological agent, initial encounter |
| T45.95XD | Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter |
| T45.95XS | Adverse effect of unspecified primarily systemic and hematological agent, sequela |
| T45.96XA | Underdosing of unspecified primarily systemic and hematological agent, initial encounter |
| T45.96XD | Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter |
| T45.96XS | Underdosing of unspecified primarily systemic and hematological agent, sequela |
| T46.0X1A | Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter |
| T46.0X1D | Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter |
| T46.0X1S | Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela |
| T46.0X2A | Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter |
| T46.0X2D | Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter |
| T46.0X2S | Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela |
| T46.0X3A | Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter |
| T46.0X3D | Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter |
| T46.0X3S | Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela |
| T46.0X4A | Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter |
| T46.0X4D | Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter |
| T46.0X4S | Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela |
| T46.0X5A | Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter |
| T46.0X5D | Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter |
| T46.0X5S | Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela |
| T46.0X6A | Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter |
| T46.0X6D | Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter |
| T46.0X6S | Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela |
| T46.1X1A | Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter |
| T46.1X1D | Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter |
| T46.1X1S | Poisoning by calcium-channel blockers, accidental (unintentional), sequela |
| T46.1X2A | Poisoning by calcium-channel blockers, intentional self-harm, initial encounter |
| T46.1X2D | Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter |
| T46.1X2S | Poisoning by calcium-channel blockers, intentional self-harm, sequela |
| T46.1X3A | Poisoning by calcium-channel blockers, assault, initial encounter |
| T46.1X3D | Poisoning by calcium-channel blockers, assault, subsequent encounter |
| T46.1X3S | Poisoning by calcium-channel blockers, assault, sequela |
| T46.1X4A | Poisoning by calcium-channel blockers, undetermined, initial encounter |
| T46.1X4D | Poisoning by calcium-channel blockers, undetermined, subsequent encounter |
| T46.1X4S | Poisoning by calcium-channel blockers, undetermined, sequela |
| T46.1X5A | Adverse effect of calcium-channel blockers, initial encounter |
| T46.1X5D | Adverse effect of calcium-channel blockers, subsequent encounter |
| T46.1X5S | Adverse effect of calcium-channel blockers, sequela |
| T46.1X6A | Underdosing of calcium-channel blockers, initial encounter |
| T46.1X6D | Underdosing of calcium-channel blockers, subsequent encounter |
| T46.1X6S | Underdosing of calcium-channel blockers, sequela |
| T46.2X1A | Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter |
| T46.2X1D | Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter |
| T46.2X1S | Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela |
| T46.2X2A | Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter |
| T46.2X2D | Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter |
| T46.2X2S | Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela |
| T46.2X3A | Poisoning by other antidysrhythmic drugs, assault, initial encounter |
| T46.2X3D | Poisoning by other antidysrhythmic drugs, assault, subsequent encounter |
| T46.2X3S | Poisoning by other antidysrhythmic drugs, assault, sequela |
| T46.2X4A | Poisoning by other antidysrhythmic drugs, undetermined, initial encounter |
| T46.2X4D | Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter |
| T46.2X4S | Poisoning by other antidysrhythmic drugs, undetermined, sequela |
| T46.2X5A | Adverse effect of other antidysrhythmic drugs, initial encounter |
| T46.2X5D | Adverse effect of other antidysrhythmic drugs, subsequent encounter |
| T46.2X5S | Adverse effect of other antidysrhythmic drugs, sequela |
| T46.2X6A | Underdosing of other antidysrhythmic drugs, initial encounter |
| T46.2X6D | Underdosing of other antidysrhythmic drugs, subsequent encounter |
| T46.2X6S | Underdosing of other antidysrhythmic drugs, sequela |
| T46.3X1A | Poisoning by coronary vasodilators, accidental (unintentional), initial encounter |
| T46.3X1D | Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter |
| T46.3X1S | Poisoning by coronary vasodilators, accidental (unintentional), sequela |
| T46.3X2A | Poisoning by coronary vasodilators, intentional self-harm, initial encounter |
| T46.3X2D | Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter |
| T46.3X2S | Poisoning by coronary vasodilators, intentional self-harm, sequela |
| T46.3X3A | Poisoning by coronary vasodilators, assault, initial encounter |
| T46.3X3D | Poisoning by coronary vasodilators, assault, subsequent encounter |
| T46.3X3S | Poisoning by coronary vasodilators, assault, sequela |
| T46.3X4A | Poisoning by coronary vasodilators, undetermined, initial encounter |
| T46.3X4D | Poisoning by coronary vasodilators, undetermined, subsequent encounter |
| T46.3X4S | Poisoning by coronary vasodilators, undetermined, sequela |
| T46.3X5A | Adverse effect of coronary vasodilators, initial encounter |
| T46.3X5D | Adverse effect of coronary vasodilators, subsequent encounter |
| T46.3X5S | Adverse effect of coronary vasodilators, sequela |
| T46.3X6A | Underdosing of coronary vasodilators, initial encounter |
| T46.3X6D | Underdosing of coronary vasodilators, subsequent encounter |
| T46.3X6S | Underdosing of coronary vasodilators, sequela |
| T46.4X1A | Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter |
| T46.4X1D | Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter |
| T46.4X1S | Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela |
| T46.4X2A | Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter |
| T46.4X2D | Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter |
| T46.4X2S | Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela |
| T46.4X3A | Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter |
| T46.4X3D | Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter |
| T46.4X3S | Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela |
| T46.4X4A | Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter |
| T46.4X4D | Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter |
| T46.4X4S | Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela |
| T46.4X5A | Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter |